nach oben

Diabetology International

Erschienen in:

13.03.2020 | Review Article

Patient decision aids in clinical practice for people with diabetes: a scoping review

verfasst von: Jodie Cornelius, Frances Doran, Elaine Jefford, Nasim Salehi

Erschienen in: Diabetology International | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

People with diabetes need to make regular choices that influence their long-term morbidity and mortality. Patient decision aids are validated tools and when used collaboratively between healthcare professionals, patients and carers, can help guide value-based discussions which encourage choices that are well informed and personally relevant.

Objective

To explore the use and effect of patient decision aids in the management of diabetes.

Method

A scoping review design was used. Medline, ProQuest, PsycINFO, Scopus, and Cumulative Index to Nursing and Allied Health Literature databases were searched for peer-reviewed articles published between January 1998 and December 2018.

Results

Patient decision aids are not commonly or widely used in diabetes management. They offer a suitable adjunct to practice within the domains of healthcare knowledge, active participation, and communication, and shared decision-making between patients and healthcare professionals.

Conclusion

Patient decision aids can offer a simple and easy-to-use method to potentially improve diabetes health literacy, through the process of shared decision-making and two-way conversations. However, there are current limitations on using them to positively influence clinical outcomes or long-term changes in self-care behaviors within the management of diabetes. Further research to explore the validity of using patient decision aids long term in these areas is required.

Nur mit Berechtigung zugänglich

Department of Health. Australian National Diabetes Strategy 2016–2020 Australian Government 2015. https://www1.health.gov.au/internet/main/publishing.nsf/content/3AF935DA210DA043CA257EFB000D0C03/$File/Australian%20National%20Diabetes%20Strategy%202016-2020.pdf. Accessed May 2018.

Roglic G, Norris S. Synopsis of the World Health Organization guidelines on second-and third-line medicines and type of insulin for the control of blood glucose levels in nonpregnant adults with diabetes mellitus. Ann Intern Med. 2018;169(6):394–7. https://doi.org/10.7326/m18-1149.CrossRefPubMed

Shaw J, Tanamas S. Diabetes: the silent pandemic and its impact of Australia: Baker IDI Diabetes and Heart Institute 2012. https://baker.edu.au/-/media/documents/impact/diabetes-the-silent-pandemic.pdf?la=en. Accessed Jan 2019.

Speight J, Conn J, Dunning T, Skinner TC. Diabetes Australia position statement. A new language for diabetes: improving communications with and about people with diabetes. Diabetes Res Clin Pract. 2012;97(3):425–31. https://doi.org/10.1016/j.diabres.2012.03.015.CrossRefPubMed

Rawal L, Tapp R, Williams E, Chan C, Yasin S, Oldenburg B. Prevention of type 2 diabetes and its complications in developing countries: a review. Int J Behav Med. 2012;19(2):121–33. https://doi.org/10.1007/s12529-011-9162-9.CrossRefPubMed

Chaney D. Diabetes education: a global perspective. Pract Diabetes. 2015;32(6):212-6a. https://doi.org/10.1002/pdi.1960.CrossRef

Zakowski J. Understanding diabetes testing: where are we, and where are we going? MLO. 2017;49(4):14–6.

Huo L, Shaw JE, Wong E, Harding JL, Peeters A, Magliano DJ. Burden of diabetes in Australia: life expectancy and disability-free life expectancy in adults with diabetes. Diabetologia. 2016;59(7):1437–45. https://doi.org/10.1007/s00125-016-3948-x.CrossRefPubMed

Trenaman L, Selva A, Desroches S, Singh K, Bissonnette J, Bansback N, et al. A measurement framework for adherence in patient decision aid trials applied in a systematic review subanalysis. J Clin Epidemiol. 2016;77:15–23. https://doi.org/10.1016/j.jclinepi.2016.03.032.CrossRefPubMed

10.

Tiktin M, Celik S, Berard L. Understanding adherence to medications in type 2 diabetes care and clinical trials to overcome barriers: a narrative review. Curr Med Res Opin. 2016;32(2):277–87. https://doi.org/10.1185/03007995.2015.1119677.CrossRefPubMed

11.

Wooley DS, Kinner TJ. Comparing perceived self-management practices of adult type 2 diabetic patients after completion of a structured ADA certified diabetes self-management education program with unstructured individualized nurse practitioner led diabetes self-management education. Appl Nurs Res. 2016;32:171–6. https://doi.org/10.1016/j.apnr.2016.07.012.CrossRefPubMed

12.

Vedhara K, Dawe K, Wetherell MA, Miles JNV, Cullum N, Dayan C, et al. Illness beliefs predict self-care behaviours in patients with diabetic foot ulcers: a prospective study. Diabetes Res Clin Pract. 2014;106(1):67–72. https://doi.org/10.1016/j.diabres.2014.07.018.CrossRefPubMed

13.

Batterham RW, Hawkins M, Collins PA, Buchbinder R, Osborne RH. Health literacy: applying current concepts to improve health services and reduce health inequalities. Public Health. 2016;132:3–12. https://doi.org/10.1016/j.puhe.2016.01.001.CrossRefPubMed

14.

Australian Commission on Safety and Quality in Health Care. Health literacy: a summary for clinicians. In: Quality Sa, editor. Sydney (AU) 2018. pp 1–8. https://www.safetyandquality.gov.au/sites/default/files/migrated/Health-literacy-a-summary-for-clinicians.pdf. Accessed Dec 2018.

15.

McCaffery KJ, Shepherd HL, Trevena L, Juraskova I, Barratt A, Butow PN, et al. Shared decision-making in Australia. Z Arztl Fortbild Qualitatssich. 2007;101(4):205–11. https://doi.org/10.1016/j.zefq.2011.04.010.CrossRefPubMed

16.

Kickbusch I, Nutbeam D. Health promotion glossary. Geneva: World Health Organization. 1998;14. https://www.who.int/healthpromotion/about/HPR%20Glossary%201998.pdf. Accessed Feb 2018.

17.

Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Crotty K. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med. 2011;155(2):97–107. https://doi.org/10.7326/0003-4819-155-2-201107190-00005.CrossRefPubMed

18.

Osborne RH, Batterham RW, Elsworth GR, Hawkins M, Buchbinder R. The grounded psychometric development and initial validation of the Health Literacy Questionnaire (HLQ). BMC Public Health. 2013;13(1):658. https://doi.org/10.1186/1471-2458-13-658.CrossRefPubMedPubMedCentral

19.

Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42(5):484–91. https://doi.org/10.1111/j.1445-5994.2012.02758.x.CrossRefPubMed

20.

Munro S, Stacey D, Lewis KB, Bansback N. Choosing treatment and screening options congruent with values: do decision aids help? Sub-analysis of a systematic review. Patient Educ Couns. 2016;99(4):491–500. https://doi.org/10.1016/j.pec.2015.10.026.CrossRefPubMed

21.

Atak N, Gurkan T, Kose K. The effect of education on knowledge, self management behaviours and self efficacy of patients with type 2 diabetes. Aust J Adv Nurs. 2008;26(2):66–74.

22.

Inga-Britt L, Kerstin B. Challenges faced in daily life by persons with type 2 diabetes: a meta-synthesis. Chron Illn. 2018. https://doi.org/10.1177/1742395318757852.CrossRef

23.

Rodriguez KM. Intrinsic and extrinsic factors affecting patient engagement in diabetes self-management: perspectives of a certified diabetes educator. Clin Ther. 2013;35(2):170–8. https://doi.org/10.1016/j.clinthera.2013.01.002.CrossRefPubMed

24.

Stacey D, Legare F, Pouliot S, Kryworuchko J, Dunn S. Shared decision making models to inform an interprofessional perspective on decision making: a theory analysis. Patient Educ Couns. 2010;80(2):164–72. https://doi.org/10.1016/j.pec.2009.10.015.CrossRefPubMed

25.

Tiedje K, Shippee ND, Johnson AM, Flynn PM, Finnie DM, Liesinger JT, et al. ‘They leave at least believing they had a part in the discussion’: understanding decision aid use and patient-clinician decision-making through qualitative research. Patient Educ Couns. 2013;93(1):86–94. https://doi.org/10.1016/j.pec.2013.03.013.CrossRefPubMedPubMedCentral

26.

Hoffmann TC, Légaré F, Simmons MB, McNamara K, McCaffery K, Trevena LJ, et al. Shared decision making: what do clinicians need to know and why should they bother? Med J Aust. 2014;201(1):35–9. https://doi.org/10.5694/mja14.00002.CrossRefPubMed

27.

Denig P, Schuling J, Haaijer-Ruskamp F, Voorham J. Effects of a patient oriented decision aid for prioritising treatment goals in diabetes: pragmatic randomised controlled trial. BMJ. 2014. https://doi.org/10.1136/bmj.g5651.CrossRefPubMed

28.

Légaré F, Stacey D, Turcotte S, Cossi M-J, Kryworuchko J, Graham ID, et al. Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Database Syst Rev. 2014. https://doi.org/10.1002/14651858.cd006732.pub3.CrossRefPubMed

29.

O’Connor AM, Wennberg JE, Legare F, Llewellyn-Thomas HA, Moulton BW, Sepucha KR, et al. Toward the ‘tipping point’: decision aids and informed patient choice. Health Aff (Millwood). 2007;26(3):716–25. https://doi.org/10.1377/hlthaff.26.3.716.CrossRefPubMed

30.

Stacey D, Legare F, Lewis K, Barry MJ, Bennett CL, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4(4):CD001431. https://doi.org/10.1002/14651858.cd001431.pub5.CrossRefPubMed

31.

Holmes-Rovner M. International Patient Decision Aid Standards (IPDAS): beyond decision aids to usual design of patient education materials. Health Expect. 2007;10(2):103–7. https://doi.org/10.1111/j.1369-7625.2007.00445.x.CrossRefPubMedPubMedCentral

32.

Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32. https://doi.org/10.1080/1364557032000119616.CrossRef

33.

Davis K, Drey N, Gould D. What are scoping studies? A review of the nursing literature. Int J Nurs Stud. 2009;46(10):1386–400.CrossRef

34.

Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5(1):69. https://doi.org/10.1186/1748-5908-5-69.CrossRefPubMedPubMedCentral

35.

Altman DG. Practical statistics for medical research. Oxford: CRC; 1990.CrossRef

36.

Buscemi N, Hartling L, Vandermeer B, Tjosvold L, Klassen TP. Single data extraction generated more errors than double data extraction in systematic reviews. J Clin Epidemiol. 2006;59:697–703.CrossRef

37.

Bailey RA, Pfeifer M, Shillington AC, Harshaw Q, Funnell MM, VanWingen J, et al. Effect of a patient decision aid (PDA) for type 2 diabetes on knowledge, decisional self-efficacy, and decisional conflict. BMC Health Serv Res. 2016;16(1):10. https://doi.org/10.1186/s12913-016-1262-4.CrossRefPubMedPubMedCentral

38.

Branda ME, LeBlanc A, Shah ND, Tiedje K, Ruud K, Van Houten H, et al. Shared decision making for patients with type 2 diabetes: a randomized trial in primary care. BMC Health Serv Res. 2013;13:301. https://doi.org/10.1186/1472-6963-13-301.CrossRefPubMedPubMedCentral

39.

Mathers N, Ng CJ, Campbell MJ, Colwell B, Brown I, Bradley A. Clinical effectiveness of a patient decision aid to improve decision quality and glycaemic control in people with diabetes making treatment choices: a cluster randomised controlled trial (PANDAs) in general practice. BMJ Open. 2012. https://doi.org/10.1136/bmjopen-2012-001469.CrossRefPubMedPubMedCentral

40.

Mullan RJ, Montori VM, Shah ND, Christianson TJ, Bryant SC, Guyatt GH, et al. The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med. 2009;169(17):1560–8. https://doi.org/10.1001/archinternmed.2009.293.CrossRefPubMed

41.

Nannenga MR, Montori VM, Weymiller AJ, Smith SA, Christianson TJ, Bryant SC, et al. A treatment decision aid may increase patient trust in the diabetes specialist. The Statin Choice randomized trial. Health Expect. 2009;12(1):38–44. https://doi.org/10.1111/j.1369-7625.2008.00521.x.CrossRefPubMedPubMedCentral

42.

Ballard AY, Kessler M, Scheitel M, Montori VM, Chaudhry R. Exploring differences in the use of the statin choice decision aid and diabetes medication choice decision aid in primary care. BMC Med Inform Decis Mak. 2017;17(1):118. https://doi.org/10.1186/s12911-017-0514-5.CrossRefPubMedPubMedCentral

43.

Wildeboer A, du Pon E, Schuling J, Haaijer-Ruskamp FM, Denig P. Views of general practice staff about the use of a patient-oriented treatment decision aid in shared decision making for patients with type 2 diabetes: a mixed-methods study. Health Expect. 2018;21(1):64–74. https://doi.org/10.1111/hex.12586.CrossRefPubMed

44.

Lee YK, Low WY, Ng CJ. Exploring patient values in medical decision making: a qualitative study. PLoS One. 2013;8(11):e80051. https://doi.org/10.1371/journal.pone.0080051.CrossRefPubMedPubMedCentral

45.

Lee PY, Khoo EM, Low WY, Lee YK, Abdullah KL, Azmi SA, et al. Mismatch between health-care professionals’ and patients’ views on a diabetes patient decision aid: a qualitative study. Health Expect. 2016;19(2):427–36. https://doi.org/10.1111/hex.12366.CrossRefPubMed

46.

Parchman ML, Zeber JE, Palmer RF. Participatory decision making, patient activation, medication adherence, and intermediate clinical outcomes in type 2 diabetes: a STARNet study. Ann Fam Med. 2010;8(5):410–7. https://doi.org/10.1370/afm.1161.CrossRefPubMedPubMedCentral

47.

Edwards M, Davies M, Edwards A. What are the external influences on information exchange and shared decision-making in healthcare consultations: a meta-synthesis of the literature. Patient Educ Couns. 2009;75(1):37–52. https://doi.org/10.1016/j.pec.2008.09.025.CrossRefPubMed

48.

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.CrossRef

Titel: Patient decision aids in clinical practice for people with diabetes: a scoping review
verfasst von: Jodie Cornelius
Frances Doran
Elaine Jefford
Nasim Salehi
Publikationsdatum: 13.03.2020
Verlag: Springer Singapore
Erschienen in: Diabetology International / Ausgabe 4/2020
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI: https://doi.org/10.1007/s13340-020-00429-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Background

Objective

Method

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes

Unique pathological changes in the pancreas of fulminant type 1 diabetes

Effect of postprandial moderate-intensity walking for 15-min on glucose homeostasis in type 2 diabetes mellitus patients

Impact of body mass index and age on the relative accuracy of self-reported energy intakes among Japanese patients with type 2 diabetes

Fulminant type 1 diabetes: recent research progress and future prospects

Fulminant type 1 diabetes: nationwide effort to elucidate genetics, etiology, and pathogenesis since 2000